360 related articles for article (PubMed ID: 28152521)
1. LncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologies.
Xu Y; Li F; Wu T; Xu Y; Yang H; Dong Q; Zheng M; Shang D; Zhang C; Zhang Y; Li X
Oncotarget; 2017 Feb; 8(9):15453-15469. PubMed ID: 28152521
[TBL] [Abstract][Full Text] [Related]
2. Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes.
Wang L; Li J; Zhao H; Hu J; Ping Y; Li F; Lan Y; Xu C; Xiao Y; Li X
Mol Biosyst; 2016 Mar; 12(3):711-20. PubMed ID: 26725846
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J
Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043
[TBL] [Abstract][Full Text] [Related]
4. Subpathway-LNCE: Identify dysfunctional subpathways competitively regulated by lncRNAs through integrating lncRNA-mRNA expression profile and pathway topologies.
Shi X; Xu Y; Zhang C; Feng L; Sun Z; Han J; Su F; Zhang Y; Li C; Li X
Oncotarget; 2016 Oct; 7(43):69857-69870. PubMed ID: 27634882
[TBL] [Abstract][Full Text] [Related]
5. Computational Inferring of Risk Subpathways Mediated by Dysfunctional Non-coding RNAs.
Xu Y; Zhang Y; Li X
Adv Exp Med Biol; 2018; 1094():87-95. PubMed ID: 30191490
[TBL] [Abstract][Full Text] [Related]
6. Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes.
Luo Z; Li Y; Liu X; Luo M; Xu L; Luo Y; Xiao B; Yang H
BMC Med Genomics; 2015 Mar; 8():13. PubMed ID: 25889429
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of lncRNA and mRNA Expression Profiles in Lung Cancer.
Chen R; Li WX; Sun Y; Duan Y; Li Q; Zhang AX; Hu JL; Wang YM; Gao YD
Clin Lab; 2017 Feb; 63(2):313-320. PubMed ID: 28182363
[TBL] [Abstract][Full Text] [Related]
8. Integrated Analysis of Long Noncoding RNA and mRNA Expression Profile in Advanced Laryngeal Squamous Cell Carcinoma.
Feng L; Wang R; Lian M; Ma H; He N; Liu H; Wang H; Fang J
PLoS One; 2016; 11(12):e0169232. PubMed ID: 28033431
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of differentially expressed profiles of lncRNAs and construction of miR-133b mediated ceRNA network in colorectal cancer.
Wu H; Wu R; Chen M; Li D; Dai J; Zhang Y; Gao K; Yu J; Hu G; Guo Y; Lin C; Li X
Oncotarget; 2017 Mar; 8(13):21095-21105. PubMed ID: 28177879
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of long non-coding RNAs in colorectal cancer: A microarray analysis.
Luo J; Xu L; Jiang Y; Zhuo D; Zhang S; Wu L; Xu H; Huang Y
Oncol Rep; 2016 Apr; 35(4):2035-44. PubMed ID: 26847923
[TBL] [Abstract][Full Text] [Related]
11. Microarray Profiling and Co-Expression Network Analysis of LncRNAs and mRNAs in Neonatal Rats Following Hypoxic-ischemic Brain Damage.
Zhao F; Qu Y; Liu J; Liu H; Zhang L; Feng Y; Wang H; Gan J; Lu R; Mu D
Sci Rep; 2015 Sep; 5():13850. PubMed ID: 26349411
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential hub-lncRNAs in ischemic stroke based on Subpathway-LNCE method.
Zheng Y; Sun S; Yu M; Fu X
J Cell Biochem; 2019 Aug; 120(8):12832-12842. PubMed ID: 30882937
[TBL] [Abstract][Full Text] [Related]
13. LncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation method.
Han J; Liu S; Sun Z; Zhang Y; Zhang F; Zhang C; Shang D; Yang H; Su F; Xu Y; Li C; Ren H; Li X
Sci Rep; 2017 Apr; 7():46566. PubMed ID: 28425476
[TBL] [Abstract][Full Text] [Related]
14. Identification of pathways significantly associated with spondyloarthropathy/ankylosing spondylitis using the sub‑pathway method.
Ding M; Guan TJ; Wei CY; Chen BH
Mol Med Rep; 2018 Oct; 18(4):3825-3833. PubMed ID: 30132545
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
16. LncDisAP: a computation model for LncRNA-disease association prediction based on multiple biological datasets.
Wang Y; Juan L; Peng J; Zang T; Wang Y
BMC Bioinformatics; 2019 Dec; 20(Suppl 16):582. PubMed ID: 31787106
[TBL] [Abstract][Full Text] [Related]
17. Identification and comprehensive characterization of lncRNAs with copy number variations and their driving transcriptional perturbed subpathways reveal functional significance for cancer.
Xu Y; Wu T; Li F; Dong Q; Wang J; Shang D; Xu Y; Zhang C; Dou Y; Hu C; Yang H; Zheng X; Zhang Y; Wang L; Li X
Brief Bioinform; 2020 Dec; 21(6):2153-2166. PubMed ID: 31792500
[TBL] [Abstract][Full Text] [Related]
18. Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer.
Li Y; Chen J; Zhang J; Wang Z; Shao T; Jiang C; Xu J; Li X
Oncotarget; 2015 Sep; 6(28):25003-16. PubMed ID: 26305674
[TBL] [Abstract][Full Text] [Related]
19. Predictive analysis of long non-coding RNA expression profiles in diffuse large B-cell lymphoma.
Zhu D; Fang C; Li X; Geng Y; Li R; Wu C; Jiang J; Wu C
Oncotarget; 2017 Apr; 8(14):23228-23236. PubMed ID: 28423571
[TBL] [Abstract][Full Text] [Related]
20. Co-LncRNA: investigating the lncRNA combinatorial effects in GO annotations and KEGG pathways based on human RNA-Seq data.
Zhao Z; Bai J; Wu A; Wang Y; Zhang J; Wang Z; Li Y; Xu J; Li X
Database (Oxford); 2015; 2015():. PubMed ID: 26363020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
